EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Granzyme B promotes matrix metalloproteinase‐1 ( MMP ‐1) release from gingival fibroblasts in a PAR1 ‐ and Erk1/2‐dependent manner: A novel role in periodontal inflammation

Mohamed Ben-Eltriki, Amir Reza Ahmadi, Yuya Nakao, Kalyan Golla, Flavia Lakschevitz, Lari Häkkinen, David J Granville, Hugh Kim

Journal of Periodontal Research · 2024-02 · 59 (1) · 94-103

DOI: 10.1111/jre.13190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontal Research, online erschienen am 24.10.2023. Verfasst von Mohamed Ben-Eltriki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 1, Periodontitis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Michael Smith Foundation for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To gain insights into how proteases signal to connective tissues cells in the periodontium.

Background

The connective tissue degradation observed in periodontitis is largely due to matrix metalloproteinase (MMP) release by gingival fibroblasts. Granzyme B (GzmB) is a serine protease whose role in periodontitis is undefined.

Methods

Human gingival crevicular fluid (GCF) samples were obtained from sites with periodontal disease and healthy control sites. GzmB was quantified in the GCF ([GzmB] GCF ) by ELISA. Gingival fibroblasts (GF) were cultured in the presence or absence of recombinant GzmB. Culture supernatants were analyzed by ELISA to quantify GzmB‐induced release of interstitial collagenase (MMP‐1). In some experiments, cells were pre‐treated with the inhibitor PD98059 to block MEK/ERK signaling. The protease‐activated receptor‐1 (PAR‐1) was blocked with ATAP‐2 neutralizing antibody prior to GzmB stimulation. Systemic MMP‐1 levels were measured in plasma from wild‐type ( WT ) and granzyme‐B‐knockout ( GzmB −/− ) mice.

Results

The [GzmB] GCF in human samples was ~4–5 fold higher at sites of periodontal disease (gingivitis/periodontitis) compared to healthy control sites, suggesting an association between GzmB and localized matrix degradation. GzmB induced a ~4–5‐fold increase in MMP‐1 secretion by cultured fibroblasts. GzmB induced phosphorylation of Erk1/2, which was abrogated by PD98059. GzmB‐induced upregulation of MMP‐1 secretion was also reduced by PD98059. Blockade of PAR‐1 function by ATAP‐2 abrogated the increase in MMP‐1 secretion by GF. Circulating MMP‐1 was similar in WT and GzmB −/− mice, suggesting that GzmB's effects on MMP‐1 release are not reflected systemically.

Conclusion

These data point to a novel GzmB‐driven signaling pathway in fibroblasts in which MMP‐1 secretion is upregulated in a PAR1‐ and Erk1/2‐dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 1PeriodontitisHumansAnimalsMiceGranzymesReceptor, PAR-1Matrix Metalloproteinase 8Gingival Crevicular FluidInflammationFibroblastsMatrix Metalloproteinase 13Matrix Metalloproteinase 3

Stichwörter der Autor:innen

Granzyme BMAP kinasesMMP-1gingival crevicular fluidperiodontitis

Substanzen

Matrix Metalloproteinase 1GranzymesReceptor, PAR-1Matrix Metalloproteinase 8Matrix Metalloproteinase 13Matrix Metalloproteinase 3

Autor:innen und Institutionen

  • Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Oral Biological and Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • ICORD Centre and Department of Pathology and Laboratory Medicine, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • Michael Smith Foundation for Health Research

Zitieren

APA

Ben-Eltriki, M., Ahmadi, A. R., Nakao, Y., Golla, K., Lakschevitz, F., Häkkinen, L., Granville, D. J., & Kim, H. (2024). Granzyme B promotes matrix metalloproteinase‐1 ( MMP ‐1) release from gingival fibroblasts in a PAR1 ‐ and Erk1/2‐dependent manner: A novel role in periodontal inflammation. Journal of Periodontal Research, 59(1), 94-103. https://doi.org/10.1111/jre.13190

Vancouver

Ben-Eltriki M, Ahmadi AR, Nakao Y, Golla K, Lakschevitz F, Häkkinen L, et al. Granzyme B promotes matrix metalloproteinase‐1 ( MMP ‐1) release from gingival fibroblasts in a PAR1 ‐ and Erk1/2‐dependent manner: A novel role in periodontal inflammation. Journal of Periodontal Research. 2024;59(1):94-103. doi:10.1111/jre.13190

BibTeX
@article{BenEltriki2024,
  author = {Ben-Eltriki, Mohamed and Ahmadi, Amir Reza and Nakao, Yuya and Golla, Kalyan and Lakschevitz, Flavia and Häkkinen, Lari and Granville, David J and Kim, Hugh},
  title = {Granzyme B promotes matrix metalloproteinase‐1 ( MMP ‐1) release from gingival fibroblasts in a PAR1 ‐ and Erk1/2‐dependent manner: A novel role in periodontal inflammation},
  journal = {Journal of Periodontal Research},
  year = {2024},
  volume = {59},
  number = {1},
  pages = {94--103},
  doi = {10.1111/jre.13190}
}
Kostenlos starten →